IonQ Takes Center Stage at Reagan Forum as $470 Million Backlog Overshadows $2 Billion Federal Snub

IonQ reports $64.7M Q1 revenue (up 755% YoY) and $470M backlog; stock surges 128.9% since April, backed by $3.3B cash and DARPA contract.

IonQ executives stepped onto the podium at the Reagan National Economic Forum in Simi Valley on Wednesday armed with an unprecedented financial haul — a record backlog of $470 million in remaining performance obligations and a fourth consecutive quarter of all-time-high revenue. The timing, they hope, will refocus the narrative away from a conspicuous absence on the list of CHIPS Act quantum computing recipients.

The US Department of Commerce last week allocated $2.013 billion in CHIPS Act funding to nine quantum companies, with IBM capturing a $1 billion slice for its "Anderon" quantum chip factory. D-Wave, Rigetti and Infleqtion each received roughly $100 million. IonQ got nothing. Yet the stock responded with a 3% gain on May 27 to $65.56, extending a rally that has seen shares surge 128.9% since April 1. The S&P 500 managed just 14.4% over the same window.

Analysts at B. Riley point to the company's deep liquidity as the cushion that makes the federal snub sting less. IonQ holds approximately $3.3 billion in cash — enough to fund operations without near-term government support. The existing contract pipeline, including a DARPA award under the HARQ (Heterogeneous Architectures for Quantum) program, further underpins the order book.

The first-quarter 2026 numbers tell a story of explosive top-line growth paired with persistent bottom-line pressure. GAAP revenue hit $64.7 million, a 755% leap from the year-ago period and well above the consensus estimate of roughly $50 million. Commercial clients accounted for 60% of sales, while international revenue from more than 30 countries contributed 35%. The net loss per share came in deeper than expected at minus $0.34 versus the minus $0.26 analysts had penciled in.

Management lifted its full-year 2026 guidance to a range of $260 million to $270 million, with second-quarter revenue forecast between $65 million and $68 million. Organic revenue growth is expected to accelerate to 100% this year from 80% in 2025.

IonQ’s role in the DARPA HARQ program involves supplying quantum memory — core chips made from synthetic diamond in quantum-grade purity — designed to link trapped-ion processors with neutral-atom and superconducting qubit architectures. The company touts a two-qubit gate fidelity of 99.99%, a metric it considers a competitive edge over alternative approaches. Whether that edge will translate into future federal funding rounds remains an open question.

Despite the rally, professional skepticism runs high. Short interest stands between 20.7% and 22.4% of the float, signaling that nearly a third of traded shares are held by bears. Institutional ownership sits at 41.4%, with Jefferies adding roughly 73,000 shares in the fourth quarter. Insider sales over the past 90 days totaled about 11,700 shares. Of the 17 analysts covering the stock, 10 rate it a buy, six a hold, and one a sell, with an average price target near $69. Zacks Investment Research calls the stock a sell.

The stock has recovered sharply from its 52-week low of $25.89, recently trading around $65.57 after swinging between $63.13 and $66.25 during the session. The broader quantum sector remains choppy — D-Wave and Rigetti have fallen from earlier highs, while Xanadu Quantum Technologies briefly jumped 17.5%. One overhang is the pending SkyWater Technology acquisition, approved by shareholders but awaiting regulatory clearance, expected in the second or third quarter. Observers flag integration risks from multiple concurrent deals as a potential drag that IonQ will need to offset with continued revenue acceleration.